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Summary : The frequency of human papil lomavirus (HPV) was investigated in 245 Japanese women (100 showing normal cytology and 145 showing abnormal cytology).
A previously presented method for the detection and typing of HPV DNA was used, where a dot blot test excluded samples that did not hybridize with HPV DNA. Positive samples were further analyzed by a southern blot procedure, to give the HPV type. A mixture of subgenomic probes of the types 6, 11, 16, 18, 31, 33 and 35 was used. HPV DNA was detected in only 2% (2/100) of patients without abnormal cytology.
In patients with abnormal cytology, the frequency was 30% (43/145) . HPV was detected in 100% (2/2) of the patients with condyloma acuminatum, 39% (26/66) of those with mild to moderate dysplasia, 44% (7/16) of those with severe dysplasia to carcinoma in situ, and 70% (7/10) of those with invasive carcinoma. Young women (20-29 yr.) had the highest HPV frequency (71%) . HPV types 16 and 18 were found in 39% of the patients with mild to moderate dysplasia, in 71% of those with severe dysplasia to carcinoma in situ and in 86% of those with invasive carcinoma.
These may be considered as high risk types for development to cancer. HPV type 31 may be considered as a moderate risk , as it was detected in 37% (16/43) of the patients . HPV types 6 and 11 were found in 100% of patients with condyloma acuminaum (2/2). To clarify the natural history of the HPV infection in the uterine cervix, it is necessary to conduct further studies.
Introduction
Epidemiologic studies of cervical precancerous lesions or cervical carcinoma, have shown that human papillomavirus (HPV) is an important etiologic factor in cervical cancers.
DNA hybridization studies have demonstrated HPV DNA in 60-90% of patients with cervical intraepithelial neoplasia (CIN), and HPV DNA has also been identified in cervical cancer and metastatic lesions (Durst et al. 1983; Boshart et al. 1984; McCance et al. 1985; Lorincz et al. 1987 ).
TANAKA, ET AL.
Specific HPV types have been linked to the various manifestations of anogenital HPV infections.
The most prevalent anogenital HPV types are HPV 6, 11, 16, 18, 31, 33, and 35 , and together they account for more than 80% of the HPV infections of the female genital tract lesions (zur Hausen, 1987) . HPV 16 and 18 have been identified in 80-90% of invasive cervical cancers (Durst et al. 1983; Boshart et al. 1984; Gissmann et al. 1986; zur Hausen, 1987) , and in the majority of high grade dysplasias, but only rarely in condyloma acuminatum.
In contrast, HPV 6 and 11 are found in approximately 90% of condyloma acuminata, in onethird of mild dysplasias, and only occasionally in genital cancer (Gissmann and zur Hausen, 1980; Gissmann et al. 1982 Gissmann et al. , 1983 . Patients infected with these two types are considered to be at a low risk for the development of malignancy, while patients infected with types 16 and 18 are considered to be at high risk for the development of malignancy. HPV types 31, 33 and 35 have been found in varying rates in dysplasias and in some cancers (Lorincz et al.1986b) , and appear to fall into an intermediate category.
The discovery that specific types of HPV have more oncogenic potential than others, together with the increased prevalence of HPV infections, has made the diagnosis of these infections important.
In Europe and America, early reports indicated that HPV DNA type 16 was rarely found in normal cervical epithelium (Shneider et al. 1985) . However, more recent studies have indicated that HPV type 16 may be recovered from 8.6-35% of normal cervical epithelium (Cox et al. 1986; Lorincz et al. 1986a; Toon et al. 1986; de Villiers et al. 1987; Meanwell et al. 1987) . In Japanese women, there have been few reports on HPV (Teshima et al. 1989; Yokota et al. 1990 DNA detected by dot blot hybridization in 100 patients, in whom the available cytology examinations were negative. Of these patients, 24 were in their 20's, 21 in their 30's, 24 in their 40's, 23 in their 50's, 6 in their 60's, and 2 were in their 70's. HPV DNA was observed in only two patients (2%). Both were pregnant women in their 20's. These two HPV positive samples were typed by southern blot, and found to contain HPV of types 16 and x, respectively.
The frequencies of HPV in the 145 patients with abnormal cytology varied with age (Table 2) . After the dot blot analysis, 45 samples were found to contain detectable amounts of HPV DNA. However with southern blot analysis of these samples, only 43 could be detected on the southern blot filter. This false positive reactivity in the dot blot analysis may be due to background reactivity or cross-reactivity to other DNA sequences. The southern blot procedure decreases these problems, by combining electrophoretic separation of the fragments and a hybridization reaction. Thus, the frequency of HPV positive samples was 30% (43/145). Among the women, 20-29 years old, HPV was detected in 71%. However, among patients older than 29 years, HPV was detected in 20-33%. Table 3 shows the rate of HPV positive samples with southern blot analysis correlated to histological analysis among the patients with an abnormal cytology. In 51 samples where no histological abnormality was observed, only 1 sample (2%) was HPV positive. This patient had previously undergone follow-up studies for dysplasia.
The positive rate for HPV was 100% (2/2) in condyloma acuminatum, 39% (26/66) in mild to moderate dysplasia, 44% (7/16) in severe dysplasia to carcinoma in situ and 70% (7/10) in invasive carcinoma.
Of the 7 HPV positive cases of invasive carcinoma, 5 cases were squamous cell carcinomas and 2 cases were adeno-squamous cell carcinomas.
HPV DNA of the known seven types were demonstrated in 36 of these samples (Table 4) . Seven cases had a distinct band, which was not related to any of the standards.
Such bands were designated as type x. These bands may represent one of the seven types tested for, but exhibiting an altered restriction enzyme cleavage, or cross-hybridization to a related and uncharacterized HPV type. When correlating the detected HPV types with the histological diagnosis, HPV 16 was detected in 35% (9/26) of cases with mild to moderate dysplasia, in 71% (5/7) with severe dysplasia to carcinoma in situ, and in 71% (5/7) with invasive carcinoma.
HPV types 18 and 31 were observed in 8% (2/26) and 46% (12/26), respectively, of cases with mild to moderate dysplasia, in 14% (1/7) and 7% (2/26), respectively, of cases with severe dysplasia to carcinoma in situ and HPV 18 in 29% (2/7) with invasive carcinoma. Dubbel infections were also identified (6 cases with types 16/31, 2 cases with types 16/18). Types 6 and 11 were observed only in the 2 cases with condyloma acuminatum.
Discussion
HPV positive cases detected by molecular biology have been found in about 1.3-38.0% of cytologically normal patients (Wagner et al. 1984; McCance et al. 1985; Schneider et al. 1985; Wickenden et al. 1985; Burk et al. 1986; Cox et al. 1986; Lorincz et al. 1986a; Toon et al. 1986; de Villiers et al. 1987; Fuchs et al. 1988 , Lorincz et al. 1990 ). De Villers et al. (1987 observed, in a survey of over 9,000 cervical swab smears, that about 11% of sexually active, healthy women were carriers of HPV of various types, including types 16 and 18. In Japan, there have been few investigations into the frequency of HPV in cytologically normal patients. Teshima et al. (1989) reported an HPV frequency in Japan of 2°0 (1/50), and Yokota et al. (1990) detected HPV in 3.3% (22/666) of asymptomatic women. In this study, HPV was detected in 2% (2/100) of patients with normal cytology, thus confirming the assumption that the frequency of HPV is around 2% for healthy women in Japan. The two HPV positive patients were pregnant women in their 20's. Schneider et al. (1987) reported that 28% of pregnant women were HPV positive compared to 12% of control patients.
Furthermore, HPV type 16 was shown to have a higher replication rate during pregnancy, perhaps due to hormonal stimulation of the virus production.
In patients with abnormal cytology, the HPV-frequency was 30% (43/145), however higher figures have been reported (35-40% by de Villiers et al. (1987) and 68% by Schneider et al. (1985) ). This low prevalence for carrying a virus might depend on differences in sexual behavior, or differences in the cytologic classification.
Minor nonspecific abnormalities (such as a slight nuclear enlargement, hyperchromasia and inflammatory atypia) were classified as abnormal cytology in the present study.
The prevalences for the different age groups differed.
In the younger generation (20-29 years), the frequency was as high as 71%. However, the effect of age on HPV prevalence has been studied elsewhere with conflicting results (de Villiers et al. 1987; McNicol et al. 1989) , and extensive HPV research in the younger generations should be undertaken.
HPV of types 6 and 11 were found in this study in 100% of subjects with condyloma acuminatum (2/2). These two types could not be detected in dysplasias or cervical carcinomas, which is in agreement with other investigators, who have identified these types in about 90% of subjects with benign condyloma acuminatum (Gissmann et al. 1980 (Gissmann et al. , 1982 (Gissmann et al. , 1983 . In contrast, HPV type 16 has been isolated from cervical carcinomas by Durst et al. (1983) , and HPV type 18 has been cloned by Boshart et al. (1984) from cervical carcinoma tissues.
In this study, HPV types 16 and 18 were present in 51% (22/43) of women with abnormal cytologies, (in 36% of those with mild to moderate dysplasia, in 71% with severe dysplasia to carcinoma in situ and in 86% with invasive carcinoma), and may be considered to be the types for a high risk for the development of cancer.
HPV type 31 has been cloned by Lorincz et al. (1987) from cervical dysplasia.
In our study, HPV type 31 was present in 37% (16/43) of the women with abnormal cytologies, (46% with mild to moderate dysplasia, 27% with severe dysplasia to carcinoma in situ, and 14% with invasive carcinoma), and may thus be a moderate risk factor.
Mixed infections with HPV types 16 and 31 were observed in 6 cases. Other investigations have also found multiple infections to be common (Bergeron et al. 1987; Fuchs et al. 1988; McNicol et al. 1989; Lorincz et al. 1990) .
In this study, the frequency of HPV infections in Japanese women was investigated and estimated.
However, to date it is still unknown how HPV infects the uterine cervix and how it participates in canceration.
Simple HPV detection methods have now become available, thus it will be possible to study the natural histories of HPV infections and CIN lesions. This knowledge may allow the physician to identify high risk individuals prior to the development of irreversible carcinogenic changes and to modify the treatment of these patients.
